Genentech Petition Rekindles Debate On Lab-Developed Test Regulation
This article was originally published in The Gray Sheet
Executive Summary
A citizen petition from biotech giant Genentech is adding new fire to the debate over whether FDA should regulate more laboratory-developed tests, and under what authority